Patrick Roth Selected Research

Methotrexate (Mexate)

9/2017	Early whole brain radiotherapy in primary CNS lymphoma: negative impact on quality of life in the randomized G-PCNSL-SG1 trial.
7/2015	Prognostic impact of B-cell lymphoma 6 in primary CNS lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Patrick Roth Research Topics

Disease

67	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 04/2006
64	Neoplasms (Cancer) 04/2024 - 11/2009
44	Glioma (Gliomas) 11/2023 - 04/2006
14	Brain Neoplasms (Brain Tumor) 01/2023 - 12/2010
12	Lymphoma (Lymphomas) 01/2023 - 05/2010
6	Seizures (Absence Seizure) 01/2024 - 04/2014
5	Epilepsy (Aura) 01/2024 - 04/2014
4	Neoplasm Metastasis (Metastasis) 01/2023 - 11/2013
3	Astrocytoma (Pilocytic Astrocytoma) 01/2024 - 08/2021
3	Virus Diseases (Viral Diseases) 02/2023 - 10/2017
3	Ependymoma 08/2021 - 04/2016
2	Hematologic Neoplasms (Hematological Malignancy) 11/2023 - 10/2020
2	Infections 09/2023 - 10/2017
2	Residual Neoplasm 01/2023 - 01/2018
2	Necrosis 01/2023 - 10/2020
2	Disease Progression 01/2023 - 01/2020
2	Meningioma (Meningiomas) 01/2023 - 01/2017
2	Multiple Myeloma 10/2020 - 07/2015
2	Inflammation (Inflammations) 09/2019 - 02/2019
2	B-Cell Lymphoma (Lymphoma, B Cell) 07/2015 - 01/2014
2	Edema (Dropsy) 11/2013 - 12/2010
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	Neurogenic Diabetes Insipidus (Central Diabetes Insipidus) 01/2023
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023

Drug/Important Bio-Agent (IBA)

22	Temozolomide (Temodar)FDA LinkGeneric 03/2024 - 03/2009
16	Proteins (Proteins, Gene)FDA Link 12/2023 - 04/2006
13	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2024 - 12/2011
10	Messenger RNA (mRNA)IBA 11/2022 - 04/2006
8	MethyltransferasesIBA 01/2024 - 04/2014
8	Bevacizumab (Avastin)FDA Link 11/2022 - 10/2014
7	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 04/2014
7	Biomarkers (Surrogate Marker)IBA 01/2024 - 08/2011
7	AntigensIBA 11/2023 - 01/2012
7	CytokinesIBA 01/2023 - 04/2014
7	LigandsIBA 12/2019 - 11/2009
6	Chimeric Antigen ReceptorsIBA 11/2023 - 01/2018
6	InterferonsIBA 01/2022 - 09/2012
6	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 02/2013
5	SteroidsIBA 01/2024 - 12/2010
5	Alkylating AgentsIBA 12/2023 - 04/2014
5	MicroRNAs (MicroRNA)IBA 12/2016 - 08/2011
5	IntegrinsIBA 07/2016 - 02/2013
4	O-(6)-methylguanineIBA 01/2024 - 04/2014
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 11/2009
4	Immune Checkpoint InhibitorsIBA 01/2022 - 06/2017
3	Proteasome Endopeptidase Complex (Proteasome)IBA 03/2024 - 11/2009
3	NivolumabIBA 01/2023 - 01/2017
3	Lomustine (CCNU)FDA Link 01/2023 - 12/2013
3	Peptides (Polypeptides)IBA 12/2022 - 02/2013
3	EpitopesIBA 10/2020 - 01/2018
3	CilengitideIBA 03/2016 - 02/2013
3	Anticonvulsants (Antiepileptic Drugs)IBA 03/2016 - 04/2014
3	CaspasesIBA 04/2014 - 11/2009
2	14- methyl- 20- oxa- 5,7,14,26- tetraazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8(27),9,11,16,21,23- decaeneIBA 04/2024 - 12/2023
2	SteamIBA 04/2024 - 12/2023
2	marizomibIBA 03/2024 - 10/2020
2	Interferon Type IIBA 02/2023 - 01/2020
2	Rituximab (Mabthera)FDA Link 01/2023 - 01/2014
2	VaccinesIBA 12/2022 - 06/2017
2	vinyltriethoxysilane (VTES)IBA 01/2022 - 01/2020
2	B7-H1 AntigenIBA 01/2022 - 10/2017
2	Phosphotransferases (Kinase)IBA 01/2022 - 11/2019
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021 - 11/2015
2	Antisense OligonucleotidesIBA 12/2019 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 11/2019 - 10/2014
2	Liposomes (Liposome)IBA 10/2019 - 01/2018
2	Small Interfering RNA (siRNA)IBA 10/2017 - 08/2010
2	Methotrexate (Mexate)FDA LinkGeneric 09/2017 - 07/2015
2	Protein Isoforms (Isoforms)IBA 01/2017 - 11/2013
2	Levetiracetam (Keppra)FDA LinkGeneric 03/2016 - 04/2014
2	Growth Differentiation Factor 15IBA 02/2016 - 08/2010
2	ImmunosorbentsIBA 01/2016 - 08/2010
2	EnzymesIBA 01/2016 - 08/2010
2	Angiogenesis InhibitorsIBA 11/2015 - 02/2013
2	Monoclonal AntibodiesIBA 07/2015 - 11/2013
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2015 - 12/2010
2	Fas Ligand Protein (Fas Ligand)IBA 02/2011 - 11/2009
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2024
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2024
1	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2024
1	Glutamic Acid (Glutamate)FDA Link 01/2024
1	Memantine (Namenda)FDA Link 01/2024
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 12/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2023
1	Anti-Infective Agents (Microbicides)IBA 09/2023
1	ManganeseIBA 09/2023
1	PlatinumIBA 01/2023
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2023
1	lisavanbulinIBA 01/2023
1	tepotinibIBA 01/2023
1	Metalloproteases (Metalloproteinases)IBA 01/2023
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2023
1	tisagenlecleucelIBA 01/2023

Therapy/Procedure

35	Therapeutics 04/2024 - 03/2009
28	Drug Therapy (Chemotherapy) 03/2024 - 03/2009
26	Radiotherapy 03/2024 - 12/2012
13	Immunotherapy 01/2023 - 08/2010
10	Chemoradiotherapy 03/2024 - 11/2015
2	Aftercare (After-Treatment) 10/2022 - 01/2019
1	Combined Modality Therapy 02/2023